2023 ASM / C-112
Optimisation of the number of biopsy passes in percutaneous non-targeted liver biopsy with 18 gauge BioPince needle
Keywords:
Liver, CT, Ultrasound, Biopsy, Quality assurance
DOI:
10.26044/ranzcr2023/C-112
References
- Chi H, Hansen BE, Tang WY, Schouten JN, Sprengers D, Taimr P, et al. Multiple biopsy passes and the risk of complications of percutaneous liver biopsy. Eur J Gastroenterol Hepatol. 2017;29(1):36-41.
- Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD. Liver biopsy. Hepatology. 2009;49(3):1017-44.
- Kumar M, Andi A, Lucas S, Wilkinson M, Ahmad I, Sabharwal T, et al. PWE-120 Liver Biopsy Using 16 G Needle: A Comparative Study. Gut. 2013;62(Suppl 1):A179-A80.
- Neuberger J, Patel J, Caldwell H, Davies S, Hebditch V, Hollywood C, et al. Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology. Gut. 2020;69(8):1382-403.
- Sirpal S, Chandok N. Primary sclerosing cholangitis: diagnostic and management challenges. Clin Exp Gastroenterol. 2017;10:265-73.